Reducing opioid related deaths for individuals who are at high risk of death from overdose: a co-production study with people housed within prison and hostel accommodation during Covid-19.

Autor: Campbell A; SSESW, Queens University Belfast, Belfast, United Kingdom., Millen S; SSESW, Queens University Belfast, Belfast, United Kingdom., Guo L; Manchester Metropolitan University, Manchester, United Kingdom., Jordan U; Faculty of Health, Social Care and Medicine, Edge Hill University, Ormskirk, United Kingdom., Taylor-Beswick A; University of Cumbria, Lancaster, United Kingdom., Rintoul C; Cranstoun, St. Andrew's House, Surbiton, United Kingdom., Diamond A; Southern Health and Social Care Trust, Craigavon, United Kingdom.

Publikováno v: Frontiers in public health [Front Public Health] 2023 Jun 15; Vol. 11, pp. 1080629. Date of Electronic Publication: 2023 Jun 15 (Print Publication: 2023).

A rapid assessment of take-home naloxone provision during COVID-19 in Europe.

Autor: McDonald R; National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; Norwegian Centre for Addiction Research, Institute of Clinical Medicine, University of Oslo, Norway. Electronic address: Rebecca.mcdonald@medisin.uio.no., Eide D; National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; Norwegian Centre for Addiction Research, Institute of Clinical Medicine, University of Oslo, Norway., Abel-Ollo K; Drug Abuse and Infectious Diseases Prevention Centre, National Institute for Health Development, Tallinn, Estonia., Barnsdale L; Public Health Scotland, UK., Carter B; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK., Clausen T; Norwegian Centre for Addiction Research, Institute of Clinical Medicine, University of Oslo, Norway., Day E; Institute for Mental Health, School of Psychology, University of Birmingham, UK., Fonseca F; Addiction Research Group, Neuroscience Research Program, Hospital del Mar Medical Research Institute, Barcelona, Spain., Holmén E; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden; Stockholm Needle Exchange, Stockholm Centre for Dependency Disorders, Stockholm, Sweden., Horsburgh K; Scottish Drugs Forum, Glasgow, UK., Kelleher M; South London and Maudsley NHS Foundation Trust, London, UK., Kåberg M; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden; Department of Medicine, Division of Infectious Diseases, Karolinska Institute, Stockholm, Sweden., Ladenhauf M; Caritas Kontaktladen und Streetwork im Drogenbereich, Graz, Austria., McAuley A; Public Health Scotland, UK; School of Health and Life Sciences, Glasgow Caledonian University, UK., Metrebian N; National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK., Neale J; National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK., Parkin S; National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK., Ratcliffe K; Change Grow Live, Birmingham, UK., Rintoul C; Cranstoun, Esher, UK., Smith J; Substance Misuse Programme, Public Health Wales, Cardiff, UK., Stifanoviciute V; Drug, Tobacco and Alcohol Control Department, Lithuania., Torrens M; Addiction Research Group, Neuroscience Research Program, Hospital del Mar Medical Research Institute, Barcelona, Spain., Thiesen H; Health Team for the Homeless, Center for Marginalized Adults and Families, Copenhagen City Social Services, Denmark., Strang J; National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; South London and Maudsley NHS Foundation Trust, London, UK.

Publikováno v: The International journal on drug policy [Int J Drug Policy] 2022 Sep; Vol. 107, pp. 103787. Date of Electronic Publication: 2022 Jul 01.

Granzymes expression patterns predict immunotherapy response and identify the heterogeneity of CD8 + T cell subsets.

Autor: Li, Jing¹ (AUTHOR), Zhang, Huibo^1,2 (AUTHOR), Wu, Jie¹ (AUTHOR), Li, Lan¹ (AUTHOR), Xu, Bin¹ (AUTHOR) xubin_oncology@whu.edu.cn, Song, Qibin¹ (AUTHOR) xubin_oncology@whu.edu.cn

Publikováno v: Cancer Biomarkers. 2023, Vol. 38 Issue 1, p77-102. 26p.

Infiltrating gliomas with FGFR alterations: Histologic features, genetic alterations, and potential clinical implications.

Autor: Dono, Antonio^1,2 (AUTHOR), El Achi, Hanadi¹ (AUTHOR), Bundrant, Bethany E.¹ (AUTHOR), Goli, Puneetha S.³ (AUTHOR), Zhu, Ping² (AUTHOR), Ozkizilkaya, Hanim I.⁴ (AUTHOR), Esquenazi, Yoshua^2,5,6 (AUTHOR) yoshua.esquenazilevy@uth.tmc.edu, Ballester, Leomar Y.^4,7 (AUTHOR) yoshua.esquenazilevy@uth.tmc.edu

Publikováno v: Cancer Biomarkers. 2023, Vol. 36 Issue 2, p117-131. 15p.

Contribution and clinical relevance of germline variation to the cancer transcriptome.

Autor: Pereira, Bernard¹ (AUTHOR), Labrot, Emma¹ (AUTHOR), Durand, Eric² (AUTHOR), Korn, Joshua M.¹ (AUTHOR), Kauffmann, Audrey² (AUTHOR), Campbell, Catarina D.¹ (AUTHOR) katie.campbell@novartis.com

Publikováno v: BMC Cancer. 6/20/2022, Vol. 22 Issue 1, p1-18. 18p.